ArticleCPT: pharmacometrics & systems pharmacology2020

A Quantitative Systems Pharmacology Model of Gaucher Disease Type 1 Provides Mechanistic Insight Into the Response to Substrate Reduction Therapy With Eliglustat.

Ruth Abrams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.